This inventor holds 1 USPTO granted patent and 10 published patent applications. Top assignee: Shanghai Apeiron Therapeutics Company Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Xiaohui Gu: Innovator in PRMT5 Inhibitors
Introduction
Xiaohui Gu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5). His work has the potential to impact various therapeutic areas.
Latest Patents
Xiaohui Gu holds a patent for PRMT5 inhibitors and methods of use. This patent includes compounds that inhibit PRMT5 activity, as well as methods for their preparation and use. Specifically, the patent details compounds of Formula (I) and their pharmaceutically acceptable salts, hydrates, and solvates.
Career Highlights
Xiaohui Gu is associated with Shanghai Apeiron Therapeutics Company Limited, where he continues to advance his research and development efforts. His work in the field has garnered attention for its innovative approach to targeting PRMT5.
Collaborations
Xiaohui Gu collaborates with Bing Yao, contributing to the advancement of their shared research interests.
Conclusion
Xiaohui Gu's innovative work in developing PRMT5 inhibitors showcases his commitment to advancing therapeutic solutions. His contributions are paving the way for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile